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ABSTRACT 
 
Background 
Anaemia in pregnancy is a major public health and economic problem worldwide, that 
contributes to both maternal and fetal morbidity and mortality. Clinical manifestations of 
anaemia in pregnancy include fetal growth restriction, preterm delivery, low birth weight, 
impaired lactation, poor maternal/infant behavioural interactions and post partum depression. 
Objective 
The aim of the study was to calculate the prevalence of anaemia in early pregnancy in a cohort of 
‘low risk’ women participating in a large international multicentre prospective study (n = 5 609), 
to identify the modifiable risk factors for anaemia in pregnancy in this cohort, and to compare 
the birth outcomes between pregnancies with and without anaemia in early gestation. 
Methods 
The study is an analysis of data that were collected prospectively during the Screening for 
Pregnancy Endpoints (SCOPE) study. Anaemia was defined according to the World Health 
Organization’s definition of anaemia in pregnancy (haemoglobin < 11g/dL). Binary logistic 
regression with adjustment for potential confounders (country, maternal age, having a marital 
partner, ethnic origin, years of schooling, and having paid work) was the main method of 
analysis. 
Results 
The hallmark findings were the low prevalence of anaemia (2.2%), that having no marital partner 
was an independent risk factor for having anaemia (OR 1.34, 95% CI 1.01-1.78), and that there 
was no statistically significant effect of anaemia on adverse pregnancy outcomes (small for 
gestational age, pre-tem birth, mode of delivery, low birth weight, APGAR score < 7 at one and 
five minutes). Adverse pregnancy outcomes were however more common in those with anaemia 
than in those without.  
Conclusion 
The absence of a marital partner is an important non-modifiable factor that should be added to 
the conceptual framework of anaemia’s determinants. Although not statistically significant, 
clinically, a trend towards a higher risk of adverse pregnancy outcomes was observed in women 
that were anaemic in early pregnancy. 
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ABBREVIATIONS 
 
BMI  Body mass index 
CDC  The United States Centers for Disease Control and Prevention 
Hb  Haemoglobin 
HIV   Human immunodeficiency virus 
IQR  Interquartile range  
KM   Kaplan-Meier 
SCOPE SCreening fOr Pregnancy Endpoints 
SD   Standard deviation 
STROBE Strengthening the Reporting of Observational Studies in Epidemiology 
WHO  World Health Organization 
 
DEFINITION OF TERMS 
Booking haemoglobin - Participant's first haemoglobin measurement at the first antenatal visit 
(g/dL) before 20 weeks gestation (typically measured during the first trimester) 
 
High green leafy vegetables consumption -  3 times per day 
 
High fruit consumption -  3 times per day 
 
Low birth weight - birth weight < 2 500g 
 
Low, middle and high income country - according to the World Bank’s classification of 
economies by GNI (gross national income) per capita 
 
Nulliparous - no previous pregnancy continuing beyond 19 weeks and 6 days gestation 
 
Preterm delivery – delivery < 37 completed weeks 
 
Socioeconomic index  - using the New Zealand Socioeconomic Index guide (Galbraith C, Jenkin 
G, Davis P, Coope P, New Zealand Social Economic Index 1996 Users Guide, Statistics New 
Zealand, Wellington, New Zealand)
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CHAPTER 1 – INTRODUCTION 
 
This chapter commences with the definition of anaemia in pregnancy, taking several factors into 
account, as it is difficult to study that which is not clearly defined. The statement of the problem 
and the study justification follow; these are bolstered by a review of the contemporary literature. 
A background on the primary study, from where the data for this secondary analysis originated, 
is given. The chapter ends with the research question and objectives of the study. 
 
1.1 Background 
Anaemia is a state where the delivery of oxygen to the tissues is impaired because of a 
quantitative or qualitative deficiency of haemoglobin (Hb) or red blood cells [1]. In pregnancy, 
according to the World Health Organization (WHO), anaemia occurs when, at sea level, the 
haemoglobin is < 11 g/dL or the haematocrit is < 33%, regardless of gestation [2,3]. 
Haemoglobin < 7 g/dL is defined by the WHO as severe anaemia and haemoglobin < 4 g/dL, as 
very severe anaemia. 
 
The United States Centers for Disease Control and Prevention’s (CDC) definition of anaemia in 
pregnancy varies, depending on the gestation. In the first and third trimesters, haemoglobin < 11 
g/dL and haematocrit < 33% is defined as anaemia; in the second trimester, the corresponding 
values are 10.5 g/dL and 32% [4]. 
 
Despite the above definitions, anaemia in pregnancy is not quite as clear-cut as alluded to above, 
because of the physiological changes that occur, which also involve the haematologic system [5]. 
 
Overall, in pregnancy, plasma volume increases to a greater extent than the increase in red cell 
mass, causing a relative decrease in the haemoglobin and haematocrit (physiologic/ 
dilutional anaemia) [5]. Some authorities maintain that additional variables of altitude, cigarette 
smoking and ethnicity may alter the definition of anaemia in individuals [6,7]. Others are of the 
opinion that altitude should not modify the definition of anaemia in pregnancy [8] and that there 
is insufficient information to alter the definition of anaemia based on ethnicity [3]. 
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These issues regarding the definition of anaemia in pregnancy are important as they have 
implications on how other variables should be taken into account when dealing with anaemia in 
pregnancy and for comparison with other studies which may use different definitions. 
 
1.2 Statement of the problem 
Studies have shown that anaemia in pregnancy has several risk factors and is associated with 
adverse maternal and peri-natal outcomes (this is discussed in detail in the literature review – 
section 1.4). Some of the serious adverse outcomes include maternal and peri-natal death; other 
adverse outcomes include low birth weight, preterm labour, etc. 
 
1.3 Justification for the study 
Given the serious problems caused by anaemia in pregnancy, it is important to continue 
characterising and quantifying the birth outcomes and identifying potentially modifiable risk 
factors associated with anaemia in pregnancy. 
 
1.4 Literature review 
 
1.4.1 Epidemiology 
According to a 2013 study, approximately 38% of pregnant women worldwide are anaemic [9]. 
The estimated prevalence of anaemia in pregnancy, according to a 2009 study, differs widely 
between continents, being highest in Africa (55.8%) and Asia (41.6 %), and lowest in Europe 
(18.7%) and North America (6.1%) [10]. The prevalence in other regions falls between these 
limits. In general, as pregnancy progresses, the prevalence of anaemia increases [11]. 
 
Anaemia in pregnancy is a major public health and economic problem worldwide, which 
contributes to both maternal and fetal morbidity and mortality; anaemia in pregnancy can also 
have profound short-term and far-reaching sequelae for the newborn [12-14].  Anaemia, even in 
early pregnancy, has been associated with adverse pregnancy outcomes [15]. Clinical 
manifestations of anaemia in pregnancy include fetal growth restriction, preterm delivery, low 
birth weight [16], impaired lactation, poor maternal/infant behavioural interactions, post partum 
depression, and increased fetal and neonatal mortality [12,13]. Iron deficiency anaemia in 
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particular has been associated with decreased work capability of adults and reduced cognitive 
function of children that may persist into adulthood; impaired motor development is another 
manifestation of anaemia. All these factors lead to economic losses [9,17]. 
 
1.4.2 Aetio-pathogenesis 
The risk factors/determinants/causes of anaemia can be found at multiple interacting levels [18]; 
the proximal causes of anaemia can be considered to be decreased red blood cell/haemoglobin 
production or increased loss of red blood cells/haemoglobin. Causative factors for this include 
nutritional, infectious and genetic entities which, in turn, are associated with access to food, 
health services, education, clean water, sanitation, etc. Ultimately, the political economy is the 
most distal cause of anaemia as it directly affects the other causes. In short, multiple interacting 
factors at different levels operate in the aetiology of anaemia, starting from the political economy 
and culminating in decreased red blood cell/haemoglobin production or increased loss of red 
blood cells/haemoglobin, and thus anaemia. The aetiology of anaemia in pregnancy must 
therefore be considered in the broader context of the “Conceptual model of the determinants of 
anaemia”, which is depicted diagrammatically by Balarajan and colleagues, in Figure 1.1. 
 
Besides the physiologic haemodilution of pregnancy, there are many risk factors for anaemia in 
pregnancy. On a global scale, some of the important risk factors include deficiency of nutrients 
such as iron (reportedly the most common risk factor), folate and vitamin B12, infections such as 
human immunodeficiency virus (HIV), malaria and hook worms, and disorders in the structure 
or production of haemoglobin such as sickle cell disease and the thalassemias [12,13]. Other risk 
factors include teenage pregnancy, ‘low’ educational level, ‘poor’ socioeconomic status, a short 
inter pregnancy interval, and high parity [18-20]. In aggregate, in high income countries 
compared to low and middle income countries, nutritional, infectious and genetic risk factors for 
anaemia are less common [21], and so anaemia in pregnancy occurs at a lower prevalence in 
high income countries [9]. 
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Figure 1.1. Conceptual model of the determinants of anaemia, reproduced with permission from 
Balarajan et al. [18] 
 
Impaired delivery of oxygen to tissues seems to be the central mechanism by which anaemia 
increases the risk of maternal organ  (brain, heart, kidney) injury and mortality [22]. Oxygen 
delivery to the uterus (and fetus) may therefore be reduced if a pregnant woman has anaemia 
[23]. 
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1.5 The SCreening fOr Pregnancy Endpoints (SCOPE) study 
 
The SCOPE study is an ongoing international prospective multicentre cohort study of 5 690 
‘low-risk’ nulliparous (no previous birth) women with singleton pregnancies in four high income 
countries, viz. New Zealand, Australia, England and Ireland (www.scopestudy.net/). The 
primary aim of the SCOPE study is to develop screening tests to predict pre-eclampsia, fetal 
growth restriction and spontaneous preterm births in a low risk population. Some of the papers 
published from the SCOPE study include those on prediction of pre-eclampsia [24,25], fetal 
growth restriction [26] and spontaneous preterm birth [27]. 
 
Details of the SCOPE study methods have been published elsewhere [28] but the methods are 
described, in part, here.  Recruitment of participants into the study started in Auckland, New 
Zealand in 2004 and finished in Cork, Ireland in 2011. The participants were aged from 16 to 45 
years at entry into the cohort. Women’s partners, along with their newborn infants, are also 
included in the study. Women before 15 weeks’ gestation were recruited into the study through 
community midwives, general practitioners, hospital antenatal clinics, obstetricians and self 
referral. Women  were excluded if they: 1) were considered to be at high risk of pre-eclampsia, 
fetal growth restriction or spontaneous preterm birth due to underlying medical conditions 
(chronic hypertension, diabetes, renal disease, systemic lupus erythematosus, anti-phospholipid 
syndrome, sickle cell disease, HIV), previous cervical knife cone biopsy, ≥ 3 previous 
terminations or ≥ 3 miscarriages, current ruptured membranes; 2) had a major uterine anomaly, a 
known major fetal anomaly or abnormal karyotype; or 3) received an intervention that could 
modify pregnancy outcome (e.g. aspirin therapy, cervical suture). 
  
At 14-16 weeks and 19- 21 weeks gestation, the participants were interviewed and examined by 
a research midwife. Blood and urine tests, and an ultrasound scan, were conducted at 19-21 
weeks. Participants were followed prospectively until birth, with pregnancy outcome data and 
baby measurements collected by research midwives. 
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1.6 Research question 
What are the risk factors for, and birth outcomes of, women with anaemia in pregnancy who 
participated in a large prospective international multicentre study from 2004 to 2011 (the SCOPE 
study)? 
 
1.7 Study objectives 
1. To calculate the prevalence of anaemia in pregnancy (haemoglobin concentration < 11 g/dL) 
in a cohort of women participating in the SCOPE study from 2004 to 2011. 
2. To identify the modifiable risk factors for anaemia in pregnancy in this cohort of women. 
3. To compare the birth outcomes between women with and without anaemia in early pregnancy, 
in this cohort. 
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CHAPTER 2 – METHODS 
 
Based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
statement [29], more information is provided in this chapter to allow the reader to make an 
informed assessment of the strengths and weaknesses of this study. Details are presented on the 
study design and setting, the study population and power of the study, data management and 
statistical analyses and, last but not least, the ethical considerations taken into account. 
 
2.1 Study design 
A retrospective secondary analysis of data that were collected prospectively during the SCOPE 
study (described in Chapter 1) was conducted. 
 
2.2 Study setting 
The cohort members were recruited from specific areas in Auckland, New Zealand; Adelaide, 
Australia; Leeds, London and Manchester, England; Cork, Ireland. These are all high income 
countries; two are in the Southern and two are in the Northern hemisphere. 
 
2.3 Study population 
A total of 5 609 ‘healthy’ nulliparous women recruited into the SCOPE study from 2004 to 2011, 
with a booking haemoglobin before 20 weeks of gestation - obtained mainly during the first 
trimester (personal communication, Philip N Baker, 2013). All 5 609 women were included in 
the secondary data analysis. The study setting and population of the SCOPE study are described 
in section 1.5. 
 
2.4 Power of the study 
To evaluate the adequacy of the sample size, a retrospective power calculation was done using 
the two-sample comparison of means method in Stata 13IC (Stata, College Station, TX) . 
The mean haemoglobin in the group of 125 participants with anaemia was 10.5 g/dL while in the 
non-anaemic group of 5 484 participants, the mean was 12.9 g/dL. Assuming a two-sided alpha 
of 0.05 and one standard deviation for both means, the power of this study to detect a difference 
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in mean haemoglobin concentration of (2.4 g/dL {12.9 g/dL-10.5 g/dL}) within the 
aforementioned parameters was 100%. 
In conclusion, the sample size was adequate to clearly differentiate between anaemic and non-
anaemic participants. 
 
2.5 Data management  
 
2.5.1 Measurement 
SCOPE study data were entered into a centrally accessed internet database with a complete audit 
trial (MedSciNet) [24]. The relevant data variables for this secondary data analysis were 
extracted by the SCOPE gatekeeper. 
 
2.5.2 Study variables 
The study variables (see below) were selected based on a priori knowledge as ascertained 
through the literature review (see Chapter 1). 
 
Women were classified as anaemic or not-anaemic as follows: 
Anaemic: anaemia in early pregnancy – adjusted haemoglobin concentration < 11 g/dL. 
 
- [Maternal haemoglobin] adjusting for cigarette smoking (a new variable) 
In the SCOPE study, data on smoking were available for three months pre-pregnancy, the first 
trimester and at the 14-16 week visit. Separate adjustments to the measured haemoglobin due to 
smoking were made for each of the three periods as well as in combination because a participant 
could, for example, smoke more during the first trimester than during three months pre-
pregnancy. The adjustment that yielded the maximum reduction in measured haemoglobin for 
each participant was used. Because smoking cigarettes has effects that can persist even 
epigenetically [30], and haematological indices can take years to return to normal after smoking 
cessation [31], an adjustment to the measured haemoglobin was made regardless of when 
maximal smoking occurred (see Table 2.1). 
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An adjustment to the haemoglobin for altitude was not made because all the participating 
SCOPE centres were below 1 000m above sea level. 
 
Not-anaemic: because being anaemic and not-anaemic are mutually exclusive, participants not 
meeting the criterion for anaemia were classified as not-anaemic. 
Table 2.1. Criteria for the adjustment of haemoglobin due to smoking cigarettes [3,6]. 
Smoking status* Measured haemoglobin adjustment (g/dL) 
Non-smoker 0 
< 10 cigarettes 0 
10-<20 cigarettes -0.3 
 20-<40 -0.5 
40 cigarettes -0.7 
* Number of cigarettes smoked per day: < 10 cigarettes ~ < ½ packet; 10-<20 cigarettes ~ ½-1 packet;  20-<40 cigarettes~ 1-2 
packets; 40 cigarettes ~ 2 packets 
 
Table 2.2. Adjustment of the haemoglobin for smoking for a hypothetical participant with 
measured haemoglobin of 11.5 g/dL. 
Number of cigarettes smoked per day Period when smoked Adjustment 
(g/dL) 
Adjusted 
haemoglobin 
(g/dL) 
15 Three months pre-pregnancy -0.3 11.2 
45 First trimester -0.7 10.8* 
5 First SCOPE visit 0 11.5 
* Adjusted haemoglobin measurement that will be used in analysis: 11.5 g/dL – 0.7 g/dL (from the 45 cigarettes) = 10.8 g/dL  
anaemic 
 
Typically, although a participant will smoke the most cigarettes per day during the three months 
pre-pregnancy, one needs to be able to detect the unusual participant who smokes more later, to 
avoid misclassification of anaemia status as would have occurred in the hypothetical participant 
if only three months pre-pregnancy smoking was considered (11.5 g/dL – 0.3 g/dL = 11.2 g/dL 
 not anaemic). 
 
For each objective, the following variables were analysed: 
Objective 1: What is the prevalence of anaemia in pregnancy? 
 Anaemia (proportion of participants with anaemia) 
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Objective 2: What are the modifiable risk factors for anaemia in pregnancy? 
 dependent variable – Anaemic/Not-anaemic 
 independent variables - Maternal age, country, marital status, ethnicity, schooling, paid 
work, body mass index, maternal socioeconomic index , fruit consumption, vegetable 
consumption, folate intake, iron and mineral intake, alcohol, psychological scales, partner 
age, paternal socioeconomic index 
 
Objective 3: What are the birth outcomes between women with and without anaemia in 
pregnancy? 
 independent variable  - Anaemic/Not-anaemic  
 dependent variables - Small for gestational age, preterm delivery, mode of delivery, low birth 
weight, APGAR score 
 
2.5.3 Data quality control 
Range checks were done using histograms and duplicates were also checked for. 
 
2.6 Statistical analyses 
 
2.6.1 Descriptive statistics 
All statistical analysis was conducted using Stata version 13IC (StataCorp LP College Station, 
TX). Continuous variables were tested for normality using histograms and inverse normal plots 
(see Appendix 1), as well as the skewness kurtosis test. The continuous variables were described 
using the mean (standard deviation - SD) if normally distributed or median (interquartile range - 
IQR) if not normally distributed. 
Frequencies (n) and percentages (%) were used to report categorical variables. To compare 
categorical variables, Pearson’s Chi-squared or Fisher’s exact tests were used, where appropriate. 
For the comparison of normally distributed continuous variables, Student’s t-test (two-sample t-
test) was used; for non-normally distributed data, the Mann-Whitney test was used. 
Kaplan-Meier (KM) curves were plotted, depicting anaemic and non-anaemic participants with 
regard to their time to delivery. The logrank test was used to ascertain the equality of survivor 
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functions with p-value < 0.05 being considered statistically significant. Although the median 
gestational ages could have been compared in each anaemia group, KM (survival) plots give a 
visual depiction and provide more information than the medians. Two-tailed p-values were 
reported. Because of multiple testing - 30 statistical tests were planned comparing anaemia status 
with 30 potential predictors - in order to reduce the chances of a false positive result (type 1 
error), Bonferonni’s method (0.05  30) was used, giving an adjusted significance level of p < 
0.002. 
 
2.6.2 Inferential statistics 
It has been suggested that methods using forward stepwise selection (or backward selection or a 
combination of both forward and backward selection) based on pre-determined p-value criteria 
are not optimal [32]. A better approach to determine which variables to include or exclude in the 
multivariable logistic regression model is by using external clinical judgment, which is the 
approach that was adopted in this analysis [32].  The model was adjusted for country, maternal 
age, having a marital partner, ethnic origin, years of schooling, and having paid work. 
Participant data may not have been independent of the SCOPE centres. To take account of this, 
the cluster option in Stata was used. 
A sensitivity analysis was done where all the participants with a missing booking haemoglobin 
were assumed to be anaemic. 
In an attempt to understand the relationship between multiple variables using a priori 
knowledge, a structural equation model – taking into account clustering, as previously mentioned 
- was developed using the observed (manifest) variables in the SCOPE study [33]. Structural 
equation modeling allows the modeling of mediating variables and is useful for the analysis of 
conceptual models [34]. As mentioned in Chapter 1, the determinants of anaemia were being 
considered in the broader context of a conceptual model [18]. 
 
2.6.3 Missing data 
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Fourteen variables had missing data. Because 14 statistical tests were done to determine if data 
were missing more from the anaemic than the non-anaemic participants or vice versa (bias 
analysis), with a target p-value of < 0.05, Bonferonni’s method (0.05  14~ 0.004) was used to 
maintain the family wise error rate. 
 
2.7 Ethical considerations 
In the SCOPE study, ethical approval was obtained from local ethics committees and all women 
provided written informed consent. For the secondary analysis of the SCOPE study dataset,  
approval was granted by the Human Research Ethics Committee of the University of the 
Witwatersrand (approved 30/09/2013, clearance certificate number M130966 – Appendix 4). To 
protect the confidentially of participants, the dataset was sent in an anonymised format, making it 
impossible to identify any participant. In addition, the dataset was stored on a password protected 
device which also has physical security. 
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CHAPTER 3 – RESULTS 
 
This chapter commences with a description of the study cohort, discusses how the measured 
haemoglobin was adjusted for cigarette smoking, presents results of the bivariable, survival, and 
multivariable analyses, and ends with a structural equation model based on the conceptual 
framework outlined in Chapter 1 (Figure 1.1). 
 
3.1 Cohort description 
Figure 3.1 depicts the flow of participants within the study; 5 690 participants were recruited into 
the SCOPE study at 14-16 weeks. Loss to follow-up was minimal: only 48 participants (0.8%) 
were lost to follow-up. Fourteen participants (0.2%) were found to be ineligible after 
recruitment, and a further 19 (0.3%) participants did not have a booking haemoglobin and were 
excluded, resulting in a study population of 5 609 participants at 14-16 weeks. Of these, 125 
(2.2%) were anaemic after adjusting for cigarette smoking according to the WHO criteria 
outlined in Chapter 2 (see Table 3.1).  
 
3.2 Adjusting the measured haemoglobin for cigarette smoking 
Without adjustment to the measured haemoglobin, 103 (1.8%) of the participants were anaemic. 
Taking into account cigarette smoking during three months pre-pregnancy resulted in 125 (2.2%) 
anaemic participants, and considering first trimester smoking yielded 112 (2.0%). When 
adjusting for smoking during the first visit (14-16 weeks), the result was the same as that from 
the unadjusted analysis, viz. 103 (1.8%) participants were anaemic. When smoking cigarettes 
during three months pre-pregnancy and the first trimester were considered together to adjust the 
measured haemoglobin, the result was the same as considering three months pre-pregnancy 
smoking alone (n = 125); these were the anaemic participants included in the analyses. 
There was no correlation between the adjusted haemoglobin and birth weight (see Appendix 2). 
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Figure 3.1. Participant flow chart, adapted from McCarthy et al. [35]. 
 
Table 3.1. Number and proportion of participants by anaemia status after adjusting the 
haemoglobin concentration for the effect of smoking cigarettes during a particular period (n = 5 
609). 
Participant’s booking 
haemoglobin (g/dL) 
before 20 weeks gestation 
Unadjusted 
 
 
 
 
n(%) 
*3 months 
pre-
pregnancy 
 
 
n(%) 
*First 
trimester 
 
 
 
n(%) 
*First visit 
(14-16 
weeks) 
 
 
n(%) 
*#3 months 
pre-
pregnancy 
and first 
trimester 
n(%) 
No anaemia (Hb 11) 5 506 (97.8) 5 484 (97.4) 5 497 (97.7) 5 506 (97.8) 5 484 (97.4) 
Anaemia (Hb<11) 103 (1.8) 125 (2.2) 112 (2.0) 103 (1.8) 125 (2.2) 
mild (11>Hb10) 87 (1.5) 105 (1.9) 95 (1.7) 86 (1.5) 105 (1.9) 
moderate (10>Hb7) 16 (0.3) 20 (0.4) 17 (0.3) 17 (0.3) 20 (0.4) 
severe (Hb<7) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
* Adjusted for the number of cigarettes smoked during that period, #adjusted for the period with the highest amount of smoking 
of the two periods. 
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3.3 Bivariable analysis 
Table 3.2 summarises the comparison of participants with and without anaemia, including the 
proportion of missing data for each variable.  Most of the variables of interest had no missing 
data and none of the missing data were associated with anaemia. The median haemoglobin for 
those with and without anaemia was 10.7 g/dL (IQR 10.4-10.8) and 12.8 g/dL (IQR 12.3–13.4), 
respectively, p < 0.001. Factors that were significantly associated with having anaemia were 
ethnic origin, reporting folate intake before pregnancy and no iron or mineral intake in the first 
trimester. 
Although 76.0% of participants did not have data on serum ferritin, 12 participants (0.88%) were 
found to have iron deficiency anemia (defined as serum ferritin < 12g/L and Hb < 11g/dL [15]). 
Participants with moderate anaemia had a mean and median gestational age at delivery of 39.8 
and 40.1 weeks respectively while the corresponding values for mildly anaemic participants were 
39.3 and 39.9 weeks. 
 
Table 3.2. Comparison of participants without and with anaemia. 
Characteristic Not anaemic 
n = 5 484 
n (%) 
Anaemic
a
 
n =125 
n (%) 
p-value
b
 
Maternal    
Age (years), median IQRc 29 (25–32) 28 (22-33) 0.2359 
Teenager 391 (7.1) 14 (11.2) 0.082 
Country    
 
0.008 
Australia 1 130 (20.6) 30 (24.0) 
Ireland 1 742 (31.8) 28 (22.4) 
New Zealand 1 980 (36.1) 42 (33.6) 
United Kingdom 632 (11.5) 25 (20.0) 
No marital partner 518 (9.5) 20 (16.0) 0.014 
Ethnic origin    
 
 
< 0.001* 
European 4 947(90.2) 97 (77.6) 
Asian 160 (2.9) 9 (7.2) 
Indian 125 (2.3) 9 (7.2) 
Polynesian 113 (2.1) 2 (1.6) 
Other (including African) 139 (2.5) 8 (6.4) 
Schooling  12 years 2 054 (37.4) 63 (50.4) 0.003 
No paid work at 15 weeks visit 795 (14.5) 29 (23.2) 0.007 
Body mass index (kg/m2) 
(ethnicity adjusted,evaluated at 14-16 
weeks) 
   
 
 
0.583 
 
 
< 18.5 82 (1.5) 2 (1.6) 
 18.5– < 25 2 998 (54.7) 76 (60.8) 
 25.0 – < 30 1 564 (28.5) 31 (24.8) 
 30 840 (15.3) 16 (12.8) 
Socioeconomic index, median IQRc 45 (28-50) 43 (27-50) 0.3058 
High fruit intake a month before 1 234 (22.5) 23 (18.4) 0.277 
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conception (consumption  3 times per 
day) 
High green leafy vegetable intake a month 
before conception (consumption  3 times 
per day) 
329 (6.0) 7 (5.6) 0.852 
Folate    
no intake before pregnancy 2 267 (41.3) 72 (57.6) < 0.001* 
no intake during first trimester 2 19 (4.0) 7 (5.6) 0.366 
Iron or mineral    
no intake before conception 3 502 (96.5) 70 (92.1) 0.043 
data missing 1 854 (33.8) 49 (39.2) 0.208 
no intake during first trimester 3 454 (95.0) 64 (84.2) < 0.001* 
data missing 1 849 (33.7) 49 (39.2) 0.200 
Alcohol (units), > 14 units per week    
3 months pre-pregnancy  602 (11.0) 15 (12.0) 0.718 
First trimester 342 (6.2) 6 (4.8) 0.510 
Psychological scales 
(evaluated at 14-16 weeks) 
   
Edinburgh Postnatal Depression 
Score  10 
1 435 (26.3) 41 (33.6) 0.069 
data missing 21 (0.4) 3 (2.4) 0.015 
Short form State-Trait Anxiety 
Inventory Score > 90th centile 
433 (7.9) 14 (11.5) 0.154 
data missing 27 (0.5) 3 (2.4) 0.028 
Perceived Stress Scale Score > 
90th centile 
483 (8.9) 18 (14.8) 0.024 
data missing 30 (0.5) 3 (2.4) 0.036 
Paternal    
Age (years), median IQRc 31 (27-35) 30 (25-34) 0.0575 
data missing 1 215 (22.2) 33 (26.4) 0.259 
Socioeconomic index, median IQRc 44 (29-50) 44 (29-50.5) 0.8451 
data missing 1 215 (22.2) 33 (26.4) 0.259 
Pregnancy outcome    
Small for gestational age (<10th 
percentile for customized birthweight 
centiles) 
617 (11.3) 13 (10.5) 0.778 
data missing 20 (0.4) 1 (0.8) 0.378 
Preterm delivery (< 37 completed weeks)    
All 347 (6.3) 9 (7.2) 0.698 
data missing 14 (0.3) 0 (0) 1.000 
Spontaneous 227 (4.2) 7 (5.6) 0.423 
data missing 14 (0.3) 0 (0) 1.000 
Mode of delivery    
 
0.307 
Unassisted vaginal 2 477 (45.3) 47 (37.9) 
Operative vaginal 1 444 (26.4) 35 (28.2) 
Pre-labour Caesarean section 486 (8.9) 11 (8.9) 
Caesarean section in labour 1 058 (19.4) 31 (25.0) 
data missing 19 (0.3) 1 (0) 0.400 
Low birth weight (< 2500g) 282 (5.2) 9 (7.3) 0.300 
data missing 27 (0.5) 1 (0.8) 0.014 
APGAR score at 1 minute < 7 496 (9.2) 16 (12.9) 0.159 
data missing 87 (1.6) 1(0.8) 0.484 
APGAR score at 5 minutes < 7 60 (1.1) 1 (0.8) 0.754 
data missing 88 (1.6) 2 (1.6) 0.997 
 a The presence or absence of anaemia was adjusted for smoking 
b Pearson’s 2 test or Fisher's exact test 
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c Mann-Whitney test 
* p-value < 0.002 was considered statistically significant, for the missing data analysis p < 0.004 was considered statistically 
significant 
 
3.4 Survival analysis 
There was no significant difference in the median gestational age at delivery for the anaemic and 
non-anaemic women (38.9 and 40.0 weeks, respectively; logrank test: p > 0.05) (see Figures 3.2 
and 3.3).  
 
Figure 3.2. Kaplan-Meier plot estimates of anaemia status (not anaemic or anaemic) and 
gestational age at delivery. 
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Figure 3.3. Kaplan-Meier plot estimates of anaemia status and gestational age at delivery. (Note 
the ‘curious’ behaviour of women with moderate anaemia who have no pre-term birth and are on 
average – median and mean - delivering later than women with mild anaemia and even those 
with no anaemia - median.). 
 
3.5 Multivariable analysis 
 
3.5.1 Anaemia as outcome 
 
Iron or mineral intake was excluded from the multivariable logistic regression models because 
33.8% of the data was missing (this was the only variable omitted because of missing data). 
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In the final model, which was of good fit (see Appendix 3), the variables that were independently 
associated with anaemia in early pregnancy were country, ethnic origin and having a marital 
partner (Table 3.3).  
 
Assuming that the 19 participants without a booking haemoglobin were anaemic lead to having 
paid work and reporting folate intake prior to pregnancy being protective of anaemia in early 
pregnancy, there were no other significant changes (see Table 3.4). 
 
3.5.2 Anaemia as risk factor 
Pregnancy outcomes were similar for anaemic and non-anaemic women in that there was no 
statistically significant finding (Table 3.5). However, the pregnancy outcome findings suggested 
a trend towards a higher risk of adverse pregnancy outcomes for anaemic women, for some but 
not all outcomes. 
 
Table 3.3. Factors associated with anaemia in early pregnancy. 
Characteristic Unadjusted OR 
(95% CI) 
p-value Adjusted OR (95% 
CI) 
p-value 
Country     
Australia Reference  Reference  
Ireland 0.61 (0.61-0.61) < 0.001 0.83-(0.68-1.01) 0.060 
New Zealand 0.80 (0.80-0.80) < 0.001 0 .93 (0.78-1.10) 0.410 
United Kingdom 1.49 (1.08-2.06) 0.016 1.34 (1.06-1.69) 0.016* 
Has marital partner Reference  Reference  
No marital partner 1.83 (1.28-2.61) 0.001 1.34 (1.01-1.78) 0.044* 
Ethnic origin     
Asian Reference  Reference  
European 0.35 (0.20-0.61) < 0.001 0.44 (0.24-0.84) 0.012* 
Other (including African) 1.02 (0.42-2.47) 0.959 0.78 (0.35-1.73) 0.536 
Polynesian 0.31 (0.24-0.41) < 0.001 0.32 (0.18-0.57) < 0.001* 
Indian 1.28 (0.75-2.18) 0.365 1.50 (0.84-2.66) 0.171 
Schooling > 12 years Reference  Reference  
Schooling  12 years 1.70 (1.39-2.08) < 0.001 1.26 (0.92-1.72) 0.156 
No paid work Reference  Reference  
Paid work 0.56 (0.43-0.73) < 0.001 0.73 (0.49-1.07) 0.108 
No folate intake before pregnancy Reference  Reference  
Folate intake before pregnancy 0.52 (0.34-0.80)  0.003 0.64 (0.40-1.03) 0.066 
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Edinburgh postnatal depression 
score  
    
< 10 Reference  Reference  
 10 1.42 (1.09-1.85) 0.009 1.06 (0.82-1.36) 0.654 
Perceived stress scale     
 90th centile Reference  Reference  
> 90th centile 1.78 (0.99-3.21) 0.054 1.47 (0.73-2.96) 0.282 
Maternal age (years) 0.97 (0.94-1.00) 0.038 1.02 (0.99-1.05) 0.180 
N=5 575 for adjusted model 
OR (Odds Ratio), CI (Confidence Interval) 
* p-values < 0.05 were considered statistically significant 
 
Table 3.4. Sensitivity analysis: assuming all 19 participants with missing haemoglobin were 
anaemic. 
Characteristic Unadjusted OR 
(95% CI) 
p-value Adjusted OR (95% 
CI) 
p-value 
Country     
Australia Reference  Reference  
Ireland 0.61 (0.61-0.61) < 0.001 0.81 (0.66-0.99) 0.041* 
New Zealand 0.87 (0.87-0.87) < 0.001 1.02 (0.85-1.21) 0.860 
United Kingdom 1.37 (1.02-1.84) 0.037 1.26 (1.00-1.59) 0.046* 
No marital partner Reference  Reference  
Has marital partner 0.58 (0.42-0.80) 0.001 0.76 (0.59-0.98) 0.036* 
Ethnic origin     
Asian Reference  Reference  
European 0.37 (0.21-0.64) < 0.001 0.48 (0.25-0.91) 0.025* 
Other (including African) 0.92 (0.37-2.28) 0.859 0.74 (0.31-1.77) 0.494 
Polynesian 0.42 (0.32-0.57) < 0.001 0.41 (0.22-0.78) 0.006* 
Indian 1.25 (0.65-2.04) 0.627 1.35 (0.68-2.68) 0.386 
Schooling > 12 years Reference  Reference  
Schooling  12 years 1.58 (1.26-1.99) < 0.001 1.19 (0.90-1.56) 0.220 
No paid work Reference  Reference  
Paid work 0.55 (0.49-0.61) < 0.001 0.68 (0.55-0.83) < 0.001* 
No folate intake before pregnancy Reference  Reference  
Folate intake before pregnancy 0.56 (0.41-0.77) < 0.001 0.69 (0.52-0.93) 0.014* 
Edinburgh postnatal depression 
score  
    
< 10 Reference  Reference  
 10 1.36 (1.06-1.75) 0.016 1.03 (0.89-1.20) 0.660 
Perceived stress scale     
 90th centile Reference  Reference  
> 90th centile 1.70 (0.95-3.04) 0.073 1.44 (0.78-2.64) 0.241 
Maternal age (years) 0.99 (0.96-1.01) 0.215 1.02 (0.98-1.05) 0.301 
N=5 594 for adjusted model 
OR (Odds Ratio), CI (Confidence Interval) 
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* p-values < 0.05 were considered statistically significant 
 
Table 3.5. Pregnancy outcomes and anaemia status. 
Characteristic Unadjusted OR 
(95% CI) 
p-value Adjusted OR (95% 
CI)* 
p-value 
Small for gestational age     
Not anaemic Reference  Reference  
Anaemic 0.92 (0.53-1.61) 0.752 0.85 (0.50-1.46) 0.560 
Pre-term birth (All)     
Not anaemic Reference  Reference  
Anaemic 1.10 (0.61-2.00) 0.752 1.05 (0.57-1.94) 0.864 
Pre-term birth (Spontaneous)     
Not anaemic Reference  Reference  
Anaemic 1.37 (0.53-3.57) 0.519 1.30 (0.48-3.50) 0.610 
Mode of delivery (unassisted 
vaginal – base outcome)# 
    
Operative vaginal     
Not anaemic Reference  Reference  
Anaemic 1.28 (0.69-2.36) 0.434 1.47 (0.75-2.87) 0.259 
Pre-labour Caesarean 
section 
    
Not anaemic Reference  Reference  
Anaemic 1.19 (0.68-2.09) 0.536 1.40 (0.74-2.62) 0.299 
Caesarean section in 
labour 
    
Not anaemic Reference  Reference  
Anaemic 1.54 (0.81-2.95) 0.189 1.73 (0.86-3.46) 0.123 
Low birth weight     
Not anaemic Reference  Reference  
Anaemic 1.44 (0.67-3.07) 0.351 1.31 (0.62-2.76) 0.485 
APGAR score at 1 minute < 7     
Not anaemic Reference  Reference  
Anaemic 0.68 (0.39-1.19) 0.178 0.71 (0.41-1.24) 0.232 
APGAR score at 5 minutes < 7     
Not anaemic Reference  Reference  
Anaemic 1.37 (0.19-10.02) 0.755 1.47 (0.21-10.3) 0.699 
OR (Odds Ratio), CI (Confidence Interval) 
# Relative risk ratio, multinomial logistic regression 
* p-values < 0.05 were considered statistically significant 
 
3.6 Structural equation model 
Structural equation modelling (see Figure 3.4) showed that folate intake 
(f10c_any_folate_prepreg ) was indirectly associated with having anaemia in early pregnancy 
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(adjusted_anemia_status3m). The ‘link’ is marital partner (f5c_marital_partnr). Having paid 
work (f5c_paidwork) was also indirectly associated with anaemia. Overall, the structural 
equation model shows the interacting nature of multiple variables. 
 
 
Figure 3.4. Structural equation  model. Connected are the statistically significant pathways 
(direct or indirect). () error terms placed on endogenous variables. Key: f5c_edu_le_12yr "Less 
than 12 years of schooling", f10c_any_folate_prepreg "Any folate intake prior to pregnancy", 
f5c_paidwork "Works in a paid job at 15w SCOPE visit", f5c_marital_partnr "Marital Partner", , 
ethnic_5_groups "Participant's main Ethnicity (5 Groups)", adjusted_anemia_status3m "Anaemia 
in early pregnancy". 
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CHAPTER 4 – DISCUSSION 
 
The chapter begins with a comparison of the study’s findings with those in previously published 
literature, followed by the study’s strengths and limitations. Finally, the conclusion and policy 
implications are presented. 
 
4.1 Comparison with other studies 
In this contemporary, large multicenter cohort of nulliparous women in their first ongoing 
pregnancy, we found a very low prevalence of anaemia. The 2.2% prevalence of anaemia in the 
SCOPE cohort differs sharply with the 22% prevalence reported from high-income regions in 
recent literature [9]. One possible explanation for this is that SCOPE participants were selected 
to be ‘low risk’ and were all nulliparous. It is well recognised that co-morbidities such as high 
parity and short birth interval can affect anaemic status [18]. Furthermore, despite the 
multicenter nature of the cohort, the ethnicity of SCOPE participants was homogeneous with 
89.9% of European ancestry. We did not adjust our findings for ethnic specific variations in 
haemoglobin concentration because of the low numbers of non-Caucasian participants and 
because there are sparse data on how to adjust the haemoglobin for ethnicity [7]. This may also 
partially explain our findings. 
 
Mandatory folic acid supplementation does not explain the lower incidence of anaemia in this 
cohort because at the time of patient recruitment none of the participating countries had 
mandatory folic acid supplementation programmes [36]. 
 
In the SCOPE cohort, not having a marital partner was associated with higher odds of having 
anaemia in early pregnancy. This is not surprising because there is evidence that involvement of 
fathers during pregnancy is associated with diminished negative maternal behaviours and better 
neonatal outcomes [37]. In addition, not having a partner suggests that the pregnancy was 
unintended and therefore women did not take steps to optimize their health prior to pregnancy. 
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In the adjusted analysis, United Kingdom participants had a lower odds of anaemia in early 
pregnancy compared to the other countries. It is difficult to untangle the disparate potential 
contributions of political economy, ecology, geography and climate, all of which are found 
within the conceptual framework of anaemia’s determinants. 
 
Previous studies have shown an association between low education [18,20], the Edinburgh 
postnatal depression score ( depression being linked to folic acid deficiency [38,39]) and teenage 
pregnancy [19], but we did not find this in our study. 
 
In our study, from a statistical significance viewpoint, anaemia was not associated with adverse 
pregnancy outcomes. However, adverse pregnancy outcomes tended to be more common in 
those with anaemia than in those without. Low birth weight and preterm delivery were similar in 
women with and without anaemia in early pregnancy. This is at odds with findings from a recent 
comprehensive systematic review and meta-analysis [15]. The low prevalence of anaemia in this 
study (with small numbers of relevant pregnancy outcomes for anaemic participants), due to the 
deliberate recruitment of ‘low risk’ women, could possibly explain the absence of an effect of 
anaemia on these adverse pregnancy outcomes. 
 
Contrary to the finding that anaemia prevalence is consistently higher in those of lower 
socioeconomic status and in those with low body weight [40], in this study the prevalence of 
anaemia was similar across paternal and maternal socioeconomic groups and body weights. 
Although confirmation of iron deficiency in pregnancy is difficult [13], iron deficiency anaemia 
is reportedly the most common cause of anaemia in pregnancy. Relatively easy access to iron in 
fortified cereals and other food products (important sources of iron in industrialized countries) 
[41], irrespective of socioeconomic status, may partly explain this lack of association. 
 
Although there were few participants with moderate anaemia, they paradoxically delivered later, 
on average, than participants with mild anaemia (of lesser severity). In fact, none of the 
participants with moderate anaemia had pre-term labour. This finding could be spurious given 
the small number of participants. However, the finding is biologically plausible because 
paradoxical results have been found in transfusion studies where individuals with more severe 
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anaemia fare better [42, 43]. We are by no means suggesting that women be made to have 
moderate anaemia as moderate anaemia seems to be associated with a longer pregnancy 
compared to mild anaemia, but the finding is worth noting because it can generate hypotheses 
about underlying biological mechanisms. 
 
4.2 Strengths 
The strengths of this study include its large multi-country prospective cohort design with 
excellent-follow up where outcome data were available for approximately 99% of participants. 
Inclusion of parental infant trios and the availability of a large number of clinical variables 
further strengthened the study. Stringent real time data monitoring helped to ensure the quality of 
the data. 
 
4.3 Limitations 
The primary study was designed to develop predictive biomarkers for three late pregnancy 
conditions, and not specifically to answer this study’s research question. ‘Healthy’ nulliparous 
women with singleton pregnancies recruited into the SCOPE study are not representative of the 
general pregnant population. The primary study was conducted in high income countries, and 
other risk factors for anaemia in pregnancy, such as malaria and hook worm infection (which are 
more common in low and middle income countries), are unlikely to be significant causes of 
anaemia in this study population. In addition, women with HIV and sickle cell disease, which are 
known risk factors/causes for anaemia, were excluded from the primary study. 
 
Cigarette smoking was evaluated by self report as is usual in clinical practice. However, 
underreporting of smoking could be a concern because cotinine levels – a sensitive marker of 
smoking tobacco – were not measured. Nevertheless, in pregnancy, self-reported tobacco use has 
been found to be a valid marker of tobacco exposure [44]. 
 
4.4 Conclusion 
The absence of a marital partner is an important non-modifiable factor that should be added to 
the conceptual framework of anaemia’s determinants. Although not statistically significant, 
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clinically, a trend towards a higher risk of adverse pregnancy outcomes was observed in women 
that were anaemic in early pregnancy. 
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APPENDIX 1 – tests for normality 
Normality tests for maternal age 
 
 
Normality tests for haemoglobin 
 
 
Normality tests for BMI 
 
 
Normality tests for birth weight 
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APPENDIX 2 – Correlation between haemoglobin and birth weight 
 
Correlation between haemoglobin and birth weight, correlation coefficient 0.0017, p-value = 
0.8972. 
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APPENDIX 3 – Model goodness of fit 
 
end of do-file
. 
                  Prob > chi2 =         0.5049
      Hosmer-Lemeshow chi2(8) =         7.30
             number of groups =        10
       number of observations =      5575
  (Table collapsed on quantiles of estimated probabilities)
Logistic model for adjusted_anemia_status3m, goodness-of-fit test
. estat gof, group(10)
. do "C:\Users\Gwinyai\AppData\Local\Temp\STD0w000000.tmp"
end of do-file
. 
                  Prob > chi2 =         0.4166
           Pearson chi2(1751) =      1762.82
 number of covariate patterns =      1766
       number of observations =      5575
Logistic model for adjusted_anemia_status3m, goodness-of-fit test
. estat gof // the model seems to be of good fit p > 0.05
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